Effects of senofilcon A and lotrafilcon B bandage contact lenses on epithelial healing and pain management after bilateral photorefractive keratectomy

Duru, Zeynep; Duru, Necati; Ulusoy, Döndü Melek

doi:10.1016/j.clae.2019.08.008

Cited by 14 publications

(20 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…BCLs reduce pain in the first several days after surgery and can reduce haze formation [33]. Several retrospective and prospective cases have compared different lens materials [34] and found minimal differences between different silicon hydrogel lenses on rate of re-epithelialization, but there may be some differences in comfort [35,36].…”

Section: Key Pointsmentioning

confidence: 99%

Role of therapeutic contact lenses in management of corneal disease

Wang

Jacobs

2022

Current Opinion in Ophthalmology

View full text Add to dashboard Cite

Purpose of reviewThe current review highlights areas of innovation and research in the use of contact lenses in the treatment of corneal ectasia and ocular surface disease.Recent findingsA series of academic reports were published by a committee of experts reviewing evidence-based practice patterns of contact lens use. There continues to be active research in the use of contact lenses in the management of keratoconus, including mini-scleral lenses, custom impression-based scleral lenses and wavefront-guided scleral lenses. Recent reports on contact lenses for ocular surface disease were primarily reviews, retrospective case reports or case series, with publications on contact lens use in corneal epithelial defects, graft-vs.-host disease, limbal stem cell deficiency and neurotrophic keratitis. There are recent publications on advances in drug-eluting contact lenses.SummaryCorneal specialists should be aware of current advances in the field of contact lens expanding their use in corneal ectasia and ocular surface disease.

show abstract

Section: Key Pointsmentioning

confidence: 99%

Role of therapeutic contact lenses in management of corneal disease

Wang

Jacobs

2022

Current Opinion in Ophthalmology

View full text Add to dashboard Cite

show abstract

“…They showed that both contact lenses were not significantly different for duration of corneal reepithelialization. [90] Therapeutic contact lenses are usually fabricated by immersion or molecular imprinting. Xie et al reported a therapeutic contact lens with a molecular imprinted structure, which had significant effects on increasing drug loading, optimizing drug release behavior, and prolonging drug residence time.…”

Section: Drug Delivery Using Contact Lensesmentioning

confidence: 99%

“…They showed that both contact lenses were not significantly different for duration of corneal reepithelialization. [ 90 ]…”

Section: Drug Delivery Using Contact Lensesmentioning

confidence: 99%

Smart Contact Lenses for Biosensing Applications

Ahadian

Liu

et al. 2021

Advanced Intelligent Systems

View full text Add to dashboard Cite

Smart contact lenses have emerged as novel wearable devices. Due to their multifunctional biosensing capabilities and highly integrated performance, they provide a great platform for the diagnosis of eye diseases and the delivery of drugs. Herein, a brief history of the development of contact lenses is given. Then, the state‐of‐the‐art design and fabrication of smart contact lenses for biomedical applications, including contact lens materials, fabrication technologies, and integration, are presented. Furthermore, biosensors implemented in contact lenses to measure lactic acid, glucose, intraocular pressure, and other key metabolites in tears are highlighted. Applications of smart contact lenses in drug delivery are also described. These unique features make smart contact lenses promising diagnostic and treatment devices. Challenges and future opportunities for further applications of smart contact lenses in biomedicine are also discussed.

show abstract

“…The main study characteristics are presented in Table 1. [2][3][4][5][6][7] The mean age of the patients was 25.98 ± 3.83 years. The mean follow-up postoperative was 2.51 ± 0.98 days.…”

mentioning

confidence: 99%

“…In 2 publications of the same year by Duru et al and Duru et al the groups analyzed 4 different materials (Balafilcon A, Samfilcon A, Senofilcon A, and Lotrafilcon B). 5,6 They concluded that wearing Samfilcon A as BCL after PRK reduces pain score, foreign body sensation, and epiphora. No BCL stood out regarding epithelial recover.…”

mentioning

confidence: 99%